TAG:
lab executive
Pap Technology Wars Expected to Intensify
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: With patience and persistence, Digene, Inc. is developing the effectiveness of its DNA-based HPV assay. Publication of recently-completed clinical trials provides evidence that Digene’s Hybrid Capture II ® HPV test, with further improvement, might become a relevant tool in…
“March 6, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
Interesting things are afoot at Esoterix, Inc., the Austin, Texas-based parent company for six specialty laboratories. President and CEO Charles L Dufesche, M.D. recently left. The new CEO is James McClintic. Esoterix has plans to become a public company and has been shopping its IPO…
Quantum Dots Targeting Multiplexed Bioassays
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Here’s another exciting new technology which promises to expand the capabilities of diagnostic testing while lowering laboratory costs. Based on research originally done during the 1970’s, quantum dots™ are nanometer-sized semiconductors with unique properties. Quantum …
“State of Lab Industry” Holds Surprises for All
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…
1999’s Top Ten Stories Reflect Speed of Change
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: This year’s round-up of the lab industry’s Top Ten most important stories lacks any compelling single theme. THE DARK REPORT’s conclusion? 1999 was a transition year. No new outside forces rattled the lab industry, allowing lab executives and pathologists to concentrate…
Court Rules Against Roche In PCR/Taq Patent Dispute
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
DECEMBER 7, 1999 WAS NOT an auspicious day for Hoffmann-LaRoche. One of its patents related to the PCR testing process was ruled invalid by a Federal District Court. The ruling involved Roche’s ’818 Taq patent, an enzyme used in the PCR process. The Court found that the patent h…
CARESIDE POC Solution in entirety, the traditional way of performing tests in the To Alter Lab Organization
By Robert Michel | From the Volume VI No. 16 – November 22, 1999 Issue
CEO SUMMARY: CARESIDE’s point-of-care testing system gives laboratory executives a new tool for bringing value-added laboratory services to clinicians. In this exclusive interview, W. Vickery Stoughton, Chairman and CEO of CARESIDE, Inc., shares his perspectives on the clinical laborato…
Internet-Based Lab Info Racing Into Marketplace
By Robert Michel | From the Volume VI No. 15 – November 1, 1999 Issue
CEO SUMMARY: It’s another roller coaster ride for clinical laboratories and pathology practices. Within 24 months, virtually all physician offices will be using web-based technology to order lab tests and receive test results. Web-based ordering/reporting of laboratory testing will driv…
Advanced Health Targets Integrated Health Networks
By Robert Michel | From the Volume VI No. 15 – November 1, 1999 Issue
“The question that every clinical laboratory must now ask is this: will my lab be a technology differentiator or a technology enabler?” Rob Alger, Advanced Health Technology CEO SUMMARY: Many hospital-based laboratories have a different missio…
California’s Physicians Face Financial Meltdown
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It’s a what-if scenario that may come true. Healthcare providers in the Golden State are going broke at an astounding rate. Physicians seem to be the hardest hit, but signs indicate that hospitals are also heading toward serious financial difficulties. In a nutshell, a deca…
CURRENT ISSUE

Volume XXXII, No. 7 – May 12, 2025
Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized